Lavino Francesco Maria
Insider CIK 1711517 · NBRV Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-09-30 | 2020-10-01 | 366 | $0.53 | $194 | 185,393 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-31 | 2020-09-02 | 366 | $0.62 | $227 | 185,759 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-20 | 2020-08-21 | 3,759 | $0.65 | $2.4K | 186,125 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 189,884 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-07-31 | 2020-08-04 | 366 | $0.76 | $278 | 178,634 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-06-30 | 2020-07-02 | 366 | $0.67 | $245 | 179,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-05-31 | 2020-06-03 | 366 | $1.14 | $417 | 179,366 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-04-30 | 2020-05-04 | 366 | $0.55 | $201 | 179,732 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-03-31 | 2020-04-02 | 366 | $0.58 | $212 | 180,098 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-02-28 | 2020-03-03 | 366 | $1.35 | $494 | 180,464 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-02-06 | 2020-02-10 | 210,000 | — | $0 | 210,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-02-06 | 2020-02-10 | 105,000 | — | $0 | 180,830 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-01-31 | 2020-02-04 | 3,892 | $1.35 | $5.3K | 75,830 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2019-08-22 | 2019-08-26 | 4,800 | $2.04 | $9.8K | 15,972 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2019-08-21 | 2019-08-21 | 3,797 | $2.08 | $7.9K | 11,172 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2019-08-21 | 2019-08-26 | 3,797 | $2.08 | $7.9K | 11,172 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 14,969 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 52,500 | — | $0 | 52,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 138,200 | — | $0 | 138,200 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-05-23 | 2018-05-29 | 2,160 | $4.60 | $9.9K | 3,719 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2017-11-29 | 2017-12-01 | 1,569 | $6.29 | $9.9K | 1,569 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2017-07-31 | 2017-08-02 | 150,000 | — | $0 | 150,000 | SEC↗ |